@ARTICLE{
author={Paller Amy S,Browning John,Nikolic Milos MI,Bodemer Christine,Murrell Dedee F,Lenon Willistine,Krusinska Eva,Reha Allen,Lagast Hjalmar,Barth Jay A},
year={2020},
title={Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study)},
journal={ORPHANET JOURNAL OF RARE DISEASES},
volume={15},
number={1},
pages={-},
document_type={Article},
}